E-ISSN: 1308-5263
Usage of U7 snRNA in gene therapy of hemoglobin S disorder - is it feasible? [Turk J Hematol]
Turk J Hematol. 2009; 26(3): 159-160

Usage of U7 snRNA in gene therapy of hemoglobin S disorder - is it feasible?

Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, 10160 Bangkok, Thailand

OBJECTIVE: OBJECTIVE: Hemoglobin (Hb) S disorder [beta6(A3)Glu-->Val, GAG-->GTG] is an important hemoglobinopathy with the highest endemicity in Africa.
METHODS: METHODS: Here, the author performs a basic bioinformatics gene ontology study to assess the effect of co-expression between nucleic acid sequence for human Hb S beta globin chain and U7.623.
RESULTS: : According to this study, the analytical results show that fully recovery of hemoglobin in both function and biological process can be got.
CONCLUSION: CONCLUSION: Here, the author proposed that U7 snRNA might be a probable tool for treatment by gene therapy approach in Hb S disorder.

Keywords: hemoglobin S, U7 snRNA


Hemoglobin S hastalığının gen tedavisinde U7 snRNA kullanımı uygun mu?

Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, 10160 Bangkok, Thailand



Viroj Wiwanitkit. Usage of U7 snRNA in gene therapy of hemoglobin S disorder - is it feasible?. Turk J Hematol. 2009; 26(3): 159-160

Corresponding Author: Viroj Wiwanitkit, Thailand


TOOLS
Full Text PDF
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
PubMed
Google Scholar